Title : Identification of a conserved drug binding pocket in TMEM16 proteins.

Pub. Date : 2022 Feb 10

PMID : 35169791






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Their modulators with therapeutic potential include 1PBC, a potent inhibitor with anti-tumoral properties, and the FDA-approved drug niclosamide that targets TMEM16F to inhibit syncytia formation induced by SARS-CoV-2 infection. Niclosamide anoctamin 6 Homo sapiens
2 Here, we report cryo-EM structures of TMEM16F associated with 1PBC and niclosamide, revealing that both molecules bind the same drug binding pocket. Niclosamide anoctamin 6 Homo sapiens